- Home
- CLDX vs WT Comparison
CLDX vs WT Comparison
Compare CLDX & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- WT
- Stock Information
- Founded
- CLDX 1983
- WT 1985
- Country
- CLDX United States
- WT United States
- Employees
- CLDX N/A
- WT N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WT Investment Bankers/Brokers/Service
- Sector
- CLDX Health Care
- WT Finance
- Exchange
- CLDX Nasdaq
- WT Nasdaq
- Market Cap
- CLDX 1.8B
- WT 1.6B
- IPO Year
- CLDX 2008
- WT N/A
- Fundamental
- Price
- CLDX $25.14
- WT $10.53
- Analyst Decision
- CLDX Buy
- WT Buy
- Analyst Count
- CLDX 7
- WT 9
- Target Price
- CLDX $64.83
- WT $12.08
- AVG Volume (30 Days)
- CLDX 914.2K
- WT 1.6M
- Earning Date
- CLDX 02-24-2025
- WT 01-31-2025
- Dividend Yield
- CLDX N/A
- WT 1.12%
- EPS Growth
- CLDX N/A
- WT N/A
- EPS
- CLDX N/A
- WT 0.31
- Revenue
- CLDX $9,976,000.00
- WT $407,884,000.00
- Revenue This Year
- CLDX N/A
- WT $26.34
- Revenue Next Year
- CLDX N/A
- WT $7.98
- P/E Ratio
- CLDX N/A
- WT $34.17
- Revenue Growth
- CLDX 128.55
- WT 23.04
- 52 Week Low
- CLDX $22.93
- WT $6.57
- 52 Week High
- CLDX $53.18
- WT $12.45
- Technical
- Relative Strength Index (RSI)
- CLDX 47.58
- WT 40.96
- Support Level
- CLDX $24.14
- WT $10.30
- Resistance Level
- CLDX $25.83
- WT $10.82
- Average True Range (ATR)
- CLDX 1.23
- WT 0.35
- MACD
- CLDX 0.02
- WT -0.10
- Stochastic Oscillator
- CLDX 48.41
- WT 22.98
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.